Epidemiological and clinical characteristics of psoriatic arthritis in northern Norway

References

• Gudjonsson J. E., Elder J. T. Psoriasis: epidemiology. Clin Dermatol 2007; 25: 535–46
   PubMed Web of Science ®Google Scholar
• Ritchlin C. Psoriatic disease – from skin to bone. Nat Clin Pract Rheumatol 2007; 3: 698–706
   PubMedGoogle Scholar
• McGonagle D., Tan A. L. Are the classification criteria for psoriatic arthritis better than existing criteria for diagnosing psoriatic arthritis?. Comment on the article by Taylor et al, Arthritis Rheum 2007; 56: 699–700
   PubMedGoogle Scholar
• Gladman D. D., Mease P. J., Strand V., Healy P., Helliwell P. S., Fitzgerald O., et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007; 34: 1167–70
   PubMed Web of Science ®Google Scholar
• Setty A. R., Choi H. K. Psoriatic arthritis epidemiology. Curr Rheumatol Rep 2007; 9: 449–54
   PubMedGoogle Scholar
• Moll J. M., Wright V. Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55–78
   PubMedGoogle Scholar
• Taylor W., Gladman D., Helliwell P., Marchesoni A., Mease P., Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665–73
   PubMed Web of Science ®Google Scholar
• Lindqvist U. R., Alenius G. M., Husmark T., Theander E., Holmstrom G., Larsson P. T. The Swedish Early Psoriatic Arthritis Register – 2‐year follow‐up: a comparison with early rheumatoid arthritis. J Rheumatol 2008; 35: 668–73
   PubMed Web of Science ®Google Scholar
• Imre K., Koo E., Sesztak M., Bosak V., Bitterova O. Genetics in patients with psoriatic arthritis [in Hungarian]. Orv Hetil 2006; 147: 2415–19
   PubMedGoogle Scholar
• Queiro R., Sarasqueta C., Belzunegui J., Gonzalez C., Figueroa M., Torre‐Alonso J. C. Psoriatic spondyloarthropathy: a comparative study between HLA‐B27 positive and HLA‐B27 negative disease. Semin Arthritis Rheum 2002; 31: 413–18
   PubMed Web of Science ®Google Scholar
• Bonfiglioli R., Conde R. A., Sampaio‐Barros P. D., Louzada‐Junior P., Donadi E. A., Bertolo M. B. Frequency of HLA‐B27 alleles in Brazilian patients with psoriatic arthritis. Clin Rheumatol 2008; 27: 709–12
   PubMedGoogle Scholar
• Khan M. A. Update on spondyloarthropathies. Ann Intern Med 2002; 136: 896–907
   PubMed Web of Science ®Google Scholar
• Gran J. T., Mellby A. S., Husby G. The prevalence of HLA‐B27 in Northern Norway. Scand J Rheumatol 1984; 13: 173–6
   PubMed Web of Science ®Google Scholar
• Bakland G., Nossent H. C., Gran J. T. Incidence and prevalence of ankylosing spondylitis in Northern Norway. Arthritis Rheum 2005; 53: 850–5
   PubMed Web of Science ®Google Scholar
• Gran J. T., Husby G., Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle‐aged population of Tromso, northern Norway. Ann Rheum Dis 1985; 44: 359–67
   PubMed Web of Science ®Google Scholar
• Gran J. T., Husby G. The epidemiology of ankylosing spondylitis. Semin Arthritis Rheum 1993; 22: 319–34
   PubMed Web of Science ®Google Scholar
• Shbeeb M., Uramoto K. M., Gibson L. E., O'Fallon W. M., Gabriel S. E. The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 2000; 27: 1247–50
   PubMed Web of Science ®Google Scholar
• Alenius G. M., Jidell E., Nordmark L., Rantapaa D. S. Disease manifestations and HLA antigens in psoriatic arthritis in northern Sweden. Clin Rheumatol 2002; 21: 357–62
   PubMed Web of Science ®Google Scholar
• Pedersen O. B., Svendsen A. J., Ejstrup L., Skytthe A., Junker P. Psoriatic arthritis in Denmark. Occurrence by self‐report and according to the CASPAR versus the Moll and Wright criteria. Ann Rheum Dis 2008; 67: 1422–6
   PubMed Web of Science ®Google Scholar
• Kaipiainen‐Seppanen O. Incidence of psoriatic arthritis in Finland. Br J Rheumatol 1996; 35: 1289–91
   PubMedGoogle Scholar
• Savolainen E., Kaipiainen‐Seppanen O., Kroger L., Luosujarvi R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J Rheumatol 2003; 30: 2460–8
   PubMed Web of Science ®Google Scholar
• Falk E. S., Vandbakk O. Prevalence of psoriasis in a Norwegian Lapp population. Acta Derm Venereol Suppl (Stockh) 1993; 182: 6–9
   PubMedGoogle Scholar
• Soderlin M. K., Kautiainen H., Skogh T., Leirisalo‐Repo M. Quality of life and economic burden of illness in very early arthritis. A population based study in southern Sweden. J Rheumatol 2004; 31: 1717–22
   PubMed Web of Science ®Google Scholar
• Love T. J., Gudbjornsson B., Gudjonsson J. E., Valdimarsson H. Psoriatic arthritis in Reykjavik, Iceland: prevalence, demographics, and disease course. J Rheumatol 2007; 34: 2082–8
   PubMed Web of Science ®Google Scholar
• Madland T. M., Apalset E. M., Johannessen A. E., Rossebo B., Brun J. G. Prevalence, disease manifestations, and treatment of psoriatic arthritis in western Norway. J Rheumatol 2005; 32: 1918–22
   PubMed Web of Science ®Google Scholar
• Fitzgerald O., Dougados M. Psoriatic arthritis: one or more diseases?. Best Pract Res Clin Rheumatol 2006; 20: 435–50
   PubMed Web of Science ®Google Scholar
• Mease P. Psoriatic arthritis update. Bull NYU Hosp Jt Dis 2006; 64: 25–31
   PubMedGoogle Scholar
• Wong K., Gladman D. D., Husted J., Long J. A., Farewell V. T. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997; 40: 1868–72
   PubMed Web of Science ®Google Scholar
• Gladman D. D., Farewell V. T., Wong K., Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998; 41: 1103–10
   PubMed Web of Science ®Google Scholar
• Ali Y., Tom B. D., Schentag C. T., Farewell V. T., Gladman D. D. Improved survival in psoriatic arthritis with calendar time. Arthritis Rheum 2007; 56: 2708–14
   PubMed Web of Science ®Google Scholar
• De Angelis R., Salaffi F., Grassi W. Prevalence of spondyloarthropathies in an Italian population sample: a regional community‐based study. Scand J Rheumatol 2007; 36: 14–21
   PubMed Web of Science ®Google Scholar
• Adomaviciute D., Pileckyte M., Baranauskaite A., Morvan J., Dadoniene J., Guillemin F. Prevalence survey of rheumatoid arthritis and spondyloarthropathy in Lithuania. Scand J Rheumatol 2008; 37: 113–19
   PubMed Web of Science ®Google Scholar
• Psoriatic arthritis and arthroplasty: a review of the literature. Bull NYU Hosp Jt Dis 2008; 66: 41–8
   PubMedGoogle Scholar
• Chandran V., Schentag C. T., Gladman D. D. Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis. Arthritis Rheum 2007; 57: 1560–3
   PubMed Web of Science ®Google Scholar
• Helliwell P. S., Porter G., Taylor W. J. Polyarticular psoriatic arthritis is more like oligoarticular psoriatic arthritis, than rheumatoid arthritis. Ann Rheum Dis 2007; 66: 113–17
   PubMed Web of Science ®Google Scholar
• Nikolaisen C., Rekvig O. P., Nossent H. C. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis. Scand J Rheumatol 2007; 36: 97–100
   PubMed Web of Science ®Google Scholar
• Ouedraogo D. D., Palazzo E., Nicaise‐Roland P., Somogyi N., Grootenboer‐Mignot S., Hayem G., et al. Anti‐cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis. Clin Exp Rheumatol 2007; 25: 930–1
   PubMedGoogle Scholar
• Taylor W. J., Helliwell P. S. Development of diagnostic criteria for psoriatic arthritis: methods and process. Curr Rheumatol Rep 2004; 6: 299–305
   PubMedGoogle Scholar